large cell lung carcinoma rhabdoid phenotype lclcrp rare histological form lung cancer currently classified variant large cell lung carcinoma lclc order lclc subclassified rhabdoid phenotype variant least malignant tumor cells must contain distinctive structures composed tangled intermediate filaments displace cell nucleus outward toward cell whorled eosinophilic inclusions lclcrp cells give microscopic resemblance malignant cells found rhabdomyosarcoma rms rare neoplasm arising transformed skeletal despite microscopic similarities lclcrp associated rhabdomyosarcoma although rhabdoid variants lclc sometimes referred rhabdoid carcinomas particular term reserved examples pure rhabdoid neoplasms ie contain cells containing histological variants lung cancers considered large extremely heterogeneous family feature widely varying genetic biological clinical characteristics different lung cancer variants recognized revision world health organization histological typing system widely recognized used lung cancer classification recent studies shown beyond doubt old classification paradigm small cell carcinoma vs nonsmall cell carcinoma obsolete correct subclassification lung cancer cases necessary assure patients receive optimum primary lung cancers carcinoma tumors composed cells originate embryonic ectoderm endoderm feature epithelial characteristics eight major groups lung carcinomas recognized lclcrp considered variants large cell carcinoma histogenesis lung cancers well understood carcinomas lung thought arise uncontrolled growth mutated transformed multipotent cancer stem cells epithelial characteristics lineage viewed light microscope transformed cancer cells lclc undifferentiated lacking specific cytological tissue architectural characteristics types subtypes variants lung election microscopic studies however shown many lclc ultrastructural characteristics tumor types ie adenocarcinoma squamous cell rhabdoid carcinomas often show similar evidence suggests cells rhabdoid phenotype result mutations occurring cells descending parent tumor leading emergence distinct populations characteristic cells rhabdoid phenotype within parent neoplasm often peripheral part missense mutations occurring cytokeratin gene rtk specific codons affects way protein products gene assume normal two threedimensional shapes may well affect way mutant proteins undergo assembly filamentous structures within cytoplasm defective protofilament products apparently accumulate aberrantly thus form distinctive whorled paranuclear inclusions characteristic rhabdoid seems likely mutations posttranslational modifications affecting cytokeratin cytokeratin vimentin protofilaments intimately involved genesis characteristic inclusions therefore rhabdoid phenotype particulars process poorly understood depend part origin stochastic genomic rhabdoid cells often express protein products suggestive aggressive dedifferentiated cells including neuroendocrine tumorrelated granulocytemacrophage colony stimulating factor vimentin intermediate filament protein usually associated noncarcinomatous tumors ie sarcoma ubiquitous rhabdoid coexpression cytokeratins vimentin associated cells undergoing epithelialmesenchymal transition undifferentiated largecell lung carcinoma common parent lung tumor rhabdoid phenotype malignant cells rhabdoid phenotype known occur many different histological variants lung cancer including sarcomatoid squamous cell combined large cell neuroencrine mucinous bronchioloalveolar carcinoma combined small cell lung lclcrp generally considered especially aggressive malignancy metastasizes widely early clinical course similar forms lung carcinoma lclcrp may spread metastasize three major ways local extension infiltration surrounding tissues lymphatic spread regional lymph nodes bloodstream hematogeneous metastasis distant organs tissues liver brain skeletoncitation needed reported lclcrp metastasize locally within airways aerogeneous spread uncommon mechanism extension wherein tumor cells migrate along lung walls septa destroy air sacs previously type metastatic behavior seen particular tumor traditionally associated almost exclusively pneumonic form pulmonary bronchioloalveolar carcinomacitation needed occasional scattered rhabdoid cell formation occurs considerable frequency lung carcinomas considered clinical according current classification criteria tumor diagnosed lclcrp undifferentiated largecell lung carcinoma contains rhabdoid cell component makes least tumor microscopic characteristics rhabdoid cells differential diagnosis lclcrp includes secondary metastatic lesions malignant melanoma lung rhabdoid phenotype mucinous adenocarcinomas particularly featuring signetring cells rhabdomyosarcoma epitheloid angiosarcoma pleural mesothelioma radiological imaging cases lclcrp single coin lesions discrete masses cases presenting multiple nodules throughout lung also cases inhomogeneousappearing consolidation ct reported well aerogenous lepidictype large centrally located lclcrp noted show signs gross necrosis cavitation imaging well associated presence large immunohistochemistry important factor results immunohistochemistry ihc staining rhabdoid lung cancers tends reflect multiphasic nature tumors typically markers expressed lclcrp include seen generic nsclcs epithelial membrane antigen ema various cytokeratins cks markers associated underlying parent pulmonary carcinoma expression immunomarkers rhabdoid cells however often noted weaker diffuse differentiated tumor also frequently express noncarcinomatous markers typically associated dedifferentiated neoplasms expression thyroid transcription commonly used marker primary lung cancers appears less frequent rhabdoid carcinomas histotypes pulmonary vimentin intermediate filament protein usually found sarcoma ubiquitously nearly expressed diffusely throughout cytoplasm rhabdoid cells often intermingled cks whorled inclusions studied reported neuroendocrinerelated markers ie neuronspecific enolase nse neural cell adhesion molecule ncam chromogranin cga synaptophysin also quite frequently expressed significant proportion rhabdoid lclcrp rare clinical trials ever conducted specifically address treatment lung cancer variant lclcrp considered form nonsmall cell lung carcinoma nsclc physicians adhere published nsclc treatment guidelines rhabdoid carcinoma cases possible radical surgical resection curative intent primary treatment choice early stage nsclcs administered without adjuvant neoadjuvant palliative chemotherapy andor radiotherapy depending disease stage performance status individual numerous clinical trials conducted nsclc several different platinumbased chemotherapy regimens shown moreorless equally lclcs subtype nsclc traditionally included many clinical trials treated like nsclcs recent trials however shown newer agents may particular effectiveness prolonging survival lclc pemetrexed particular shown significant reduction hazard ratio death used patients taxanebased paclitaxel docetaxel chemotherapy shown induce complete sustained response liver metastasis case lccrp laterappearing metastasis within mediastinal lymph nodes case also showed durable response taxane also reports rhabdoid carcinomas expressing vascular endothelial growth factor suggesting targeted molecular therapy vegf blocking monoclonal antibodies bevacizumab may active however evidence suggests caution must used treating cavitated rhabdoid tumor one contains significant components squamous cell differentiation large tumors containing major blood vessels due potential high risk lifethreatening pulmonary recent study reported case wherein courses adjuvant therapy cisplatin paclitaxel followed oral gefitinib used complete resection patient recurrence months largevolume lclcrp may show significant central necrosis cavitation prudence dictates oncologists use extreme caution contemplating therapeutic use bevacizumab antivegf compounds antiangiogenesis agents general associated greatly increased risk severe hemorrhage hemoptysis may quickly fatal cavatated pulmonary squamous cell carcinomas similar elevated risks also noted tumors located near containing large blood lclcrp considered especially aggressive tumors dismal many published cases shown short survival times studies suggest proportion rhabdoid cells tumor increases prognosis tends although pronounced proportion rhabdoid cells exceeds regard parent neoplasms lclc adenocarcinomas rhabdoid features reported worse prognoses adenocarcinomas without rhabdoid although adenocarcinoma rhabdoid phenotype tumor variant specifically recognized distinct entity classification case reports rhabdoid carcinomas recurring unusually long periods unusual fastgrowing aggressive tumor type one report described early stage patient whose tumor recurred years initial although rapidly progressive fulminant courses seem rule entity longterm survival also noted even postmetastectomy late stage distant metastatic although reliable comprehensive incidence statistics nonexistent lclcrp rare tumor hundred cases described scientific literature lclcs made lung cancers historical equating approximately cases per year lclc cases estimated eventually develop rhabdoid phenotype tumor evolution one large series surgically resected lung cancers cases diagnosed lclcrp another highly selected series largecell lung carcinoma cases tumors diagnosed rhabdoid phenotype using criterion another least rhabdoid cell appears likely therefore lclcrp probably comprises lung malignancies similar nearly variants lung carcinoma large cell lung carcinoma rhabdoid phenotype appears highly related tobacco smoking also appears significantly common males rhabdoid phenotype may exclusively associated certain missense mutations gene possibly vimentin gene see may prove possible develop specific monoclonal antibodies certain peptides aberrant gene products may target rhabdoid cells specific mutations recent reports suggest antibodies may easier get interior cells previously thoughtcitation needed although colby colleagues first report primary lung cancer rhabdoid phenotype paper published cells characteristic features previously noted noted occur rare extremely aggressive form kidney cancer appears almost exclusively young children called wilms lclcrp first recognized distinct entity published revision world health organization lung tumor histological typing placement classification schema went unchanged httpsenwikipediaorgwikilargecelllungcarcinomawithrhabdoidphenotype